Garza GEJ, Guerrero ÁF, Téllez JH

Language: Spanish
References: 17
Page: 6-12
PDF size: 402.22 Kb.

ABSTRACT

Objective: To evaluate the clinical effectiveness of EMD (MDE in Spanish) and BCPH (FCB) combined in the treatment of intrabony defects for periodontal regeneration. Introduction: Periodontal disease is characterized by inflammation, gingival bleeding, attachment loss and formation of intrabony defects. The EMD promotes the proliferation, migration, adhesion and differentiation of cells associated with periodontal tissue health; reintegration is a cellular intrinsic fiber cementum on the root surface and may induce the formation of new mineralized connective tissue. Using the BCPH (FCB) we keep the space and a scaffold for repopulation differentiated cell. Methodology: Patients were selected graduate Periodontics UAT with moderate to severe periodontal disease with vertical defects › 3 mm, radiographically visible, with 2 or 3 bony walls, unencumbered systemically, with good oral hygiene index. The study was conducted with four groups, which open and curettage was performed in some different biomaterials placement: 1) Without biomaterial, 2) EMD, 3) BCPH (FCB) and 4) EMD + BCPH (FCB). Initial measurements were taken and control at 6 months. Results: At the end of the study was clinical and radiographic evaluation of all groups, demonstrating significant improvement in periodontal indexes so that the option of a combination of biomaterials is an alternative to results and offers greater potential for regenerative therapy organ tissues around the teeth, and represents a new method of regeneration. Conclusions: The enamel matrix derivated is considered a biomaterial with potential in regenerative stimulation and combination with biomaterials such as allografts and alloplastic represent efficient options to achieve the restoration by regenerating bone and periodontal tissue.

REFERENCES

1. Herbert W. Atlas a color de periodontología. Edición 2009. pp. 1, 51, 98-99.

2. Henry M. The infrabony pocket: classification and treatment. J Periodontology 1958. pp. 272-291.

3. Godman HM, Cohen W. The infrabony pocket: Classification and treatment. J Periodontology 1958: (272-291).

4. Vastardis S et al. Evaluation of alogenic bone graft substitute for treatment of periodontal osseous defect: 6 Month Clinical results. Jan 2006.

5. Sculean A. Healing of human intrabony defects following regenerative periodontal therapy with an enamel matrix protein derivated alone or combined with a bioactive glass a controlled. J Clin Periodontol 2005; 32: 111-117.

6. Carinci F et al. Effects of emdogain on osteoblast gene expression. Oral Diseases 2006; 12: 329-342.

7. Bosshardt DD et al. Effects of enamel matrix proteins on tissue formation along the roots of human teeth. J Periodontol Res 2005; 40: 158-167.

8. Sculean A et al. Nine–years results following treatment of intrabony periodontal defects with an enamel matrix derivative: report of 26 cases. J Periodontics Restorative Dent 2007; 27 (3): 221-229.

9. Consensus Report. Position Paper: Periodontal Regeneration around natural teeth. Ann Periodontol 1996; 1: 667-670.

10. Dori IF et al. Clinical evaluation of an enamel matrix protein derivate combined with either natural bone mineral or b-tricalcium phosphate. Periodontol 2005; 76 (12): 2236-2243.

11. Schwarz F et al. Guided bone regeneration at dehiscence-type defects using biphasic hydroxiapatite + beta tricalcium phosphate or a collagen-coated natural bone mineral: an immunohistochemical study in dogs. Int J Oral Maxillofac Surg 2007; 36: 1198-1206.

12. Gauthier O et al. Macroporus biphasic calcium phosphate ceramics: influence of macropore diameter and macroporosity percentage on bone in growth. Biomaterials 1998; 19 (1-3): 133-139.

13. Pousa X y col. Emdogain: Últimos avances en regeneración periodontal. Avances en Periodoncia. 2005. pp. 229-233.

14. Hammarström L. Enamel matrix derivative, cementum development and regeneration. J Clin Periodontol 1997; 24: 658-668.

15. Jepsen S et al. Clinical outcomes after treatment of intra-bony defects with an EMD/synthetic bone graft or EDM alone: a multicentre randomized-controlled clinical trial. J Clin Periodontol 2008; 35: 420-428.

16. Sculean A et al. Treatment of intrabony defects with enamel matrix proteins or bioabsorbable membranes. A 4-year follow-up split-mouth study. J Periodontol 2001; 72: 1695-1701.

17. Venezia E et al. The use of enamel matrix derivative in the treatment of periodontal defects: A Literature Review and Meta-analysis. Crit Rev Oral Biol Med 2004; 15 (6): 382-402.